CLDI
Calidi Biotherapeutics, Inc.
$0.14
0.00 (-1.39%)
At close · Jul 8
Market Cap
$2.74M
Shares
19,311,625
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2026-04-28 | Corporate Presentation - April 2026 | Presentation |
| 2026-04-21 | CLD-401, an IL-15 superagonist gene medicine via redtail virotherapy, achieves sustained tumor eradication | Event |
| 2026-04-19 | Redtail: A dual-programmable virotherapy platform for systemic tumor targeting and localized gene delivery | Event |
| 2026-02-20 | AACR-IO Poster - RedTail: A Next-Generation Systemic Platform for Tumor-Specific Delivery of BiTEs and Immune Activation | Event |
| 2026-02-06 | Corporate Presentation - February 2026 | Presentation |
| 2025-11-07 | 2025 SITC Investor Day Presentation | Presentation |
| 2025-03-18 | Calidi Biotherapeutics (NYSE American: CLDI) Investor Webinar - March 18, 2025 | Event |
| 2024-09-11 | Calidi Biotherapeutics Webinar | Event |
| 2021-12-30 | Test Item: Reports Solid Fourth Quarter Results | Event |
| 2021-01-05 | Test Item: Reports Solid First Quarter Results | Event |
| 2020-10-02 | Test Item: Presents at Morgan Stanley Conference | Conference |
| 2020-02-13 | Test Item: Presents at Morgan Stanley Conference | Conference |